Midostaurin (PKC412) demonstrates a high rate of durable responses in patients with advanced systemic mastocytosis: Results from the fully accrued global phase 2 CPKC412D2201 trial Meeting Abstract
| Authors: | Gotlib, J.; Kluin-Nelemans, H. C.; George, T. I.; Akin, C.; Sotlar, K.; Hermine, O.; Awan, F.; Hexner, E. O.; Mauro, M.; Sternberg, D.; Villeneuve, M.; Emery-Salbert, F.; Stanek, E.; Hartmann, K.; Horny, H. P.; Valent, P.; Reiter, A. |
| Abstract Title: | Midostaurin (PKC412) demonstrates a high rate of durable responses in patients with advanced systemic mastocytosis: Results from the fully accrued global phase 2 CPKC412D2201 trial |
| Meeting Title: | 56th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 124 |
| Issue: | 21 |
| Meeting Dates: | 2014 Dec 6-9 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2014-12-06 |
| Language: | English |
| ACCESSION: | WOS:000349243502182 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V124.21.636.636 |
| Notes: | Meeting Abstract: 636 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos |
